X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3658) 3658
Publication (359) 359
Newsletter (218) 218
Book Chapter (39) 39
Book Review (28) 28
Newspaper Article (11) 11
Conference Proceeding (9) 9
Dissertation (7) 7
Government Document (2) 2
Data Set (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1866) 1866
index medicus (1065) 1065
humans (986) 986
xanthine oxidase (882) 882
xanthine oxidase - metabolism (844) 844
male (834) 834
biochemistry & molecular biology (769) 769
rats (725) 725
xanthine (682) 682
oxidative stress (576) 576
oxidases (573) 573
xanthine-oxidase (521) 521
xanthine oxidoreductase (519) 519
female (508) 508
xanthine dehydrogenase - metabolism (471) 471
oxidation-reduction (447) 447
uric acid (436) 436
enzymes (419) 419
research (369) 369
liver - enzymology (361) 361
kinetics (356) 356
mice (342) 342
xanthine dehydrogenase (339) 339
oxidoreductases (328) 328
allopurinol (325) 325
xanthine oxidase - antagonists & inhibitors (323) 323
nitric oxide (320) 320
oxidoreductase (310) 310
molybdenum compounds (309) 309
pharmacology & pharmacy (301) 301
analysis (275) 275
dehydrogenase (266) 266
cell biology (262) 262
purines (259) 259
molybdenum (258) 258
cattle (253) 253
reactive oxygen species - metabolism (244) 244
iron compounds (241) 241
aldehyde oxidase (233) 233
superoxide (233) 233
oxidoreductases - metabolism (225) 225
enzyme inhibitors - pharmacology (222) 222
reactive oxygen species (222) 222
physiological aspects (218) 218
free radicals (217) 217
hyperuricemia (216) 216
metabolism (214) 214
xanthines (214) 214
antioxidants (200) 200
mechanism (197) 197
proteins (195) 195
nitric-oxide (174) 174
physiology (168) 168
superoxides - metabolism (168) 168
oxidase (166) 166
rats, sprague-dawley (165) 165
gout (164) 164
crystal-structure (163) 163
allopurinol - pharmacology (162) 162
liver (162) 162
middle aged (159) 159
uric-acid (159) 159
xanthine dehydrogenase - genetics (156) 156
cardiac & cardiovascular systems (155) 155
nitric oxide - metabolism (155) 155
in vitro techniques (154) 154
rats, wistar (154) 154
liver - metabolism (153) 153
adult (152) 152
hypertension (150) 150
research article (145) 145
rodents (141) 141
inflammation (140) 140
time factors (138) 138
uric acid - blood (138) 138
inhibition (137) 137
article (136) 136
biophysics (136) 136
expression (135) 135
aldehyde oxidoreductases - metabolism (134) 134
binding sites (131) 131
nitric-oxide synthase (131) 131
ketone oxidoreductases - metabolism (130) 130
multidisciplinary sciences (130) 130
endocrinology & metabolism (129) 129
uric acid - metabolism (127) 127
milk - enzymology (126) 126
chemistry (123) 123
mutation (122) 122
purification (122) 122
electron spin resonance spectroscopy (121) 121
xanthine oxidase - chemistry (121) 121
free-radicals (120) 120
hypoxia (120) 120
oxygen (120) 120
xanthine dehydrogenase - antagonists & inhibitors (120) 120
disease models, animal (119) 119
molecular sequence data (119) 119
ischemia (117) 117
molybdenum - metabolism (116) 116
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3832) 3832
German (23) 23
Japanese (20) 20
French (16) 16
Russian (16) 16
Spanish (10) 10
Chinese (4) 4
Italian (4) 4
Czech (2) 2
Polish (2) 2
Portuguese (2) 2
Arabic (1) 1
Dutch (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 01/2010, Volume 121, Issue 1, pp. 98 - 109
Background-Pulmonary arterial hypertension is a progressive proliferative vasculopathy of the small pulmonary arteries that is characterized by a primary... 
Hypoxia | Nitric oxide | Pulmonary artery smooth muscle cells | Xanthine oxidoreductase | Monocrotaline sodium | hypoxia | nitric oxide | xanthine oxidoreductase | ISCHEMIA/REPERFUSION INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | ORGANIC NITRATES | monocrotaline sodium | ACTIVATED-PROTEIN-KINASE | CELL-PROLIFERATION | EXERCISE CAPACITY | pulmonary artery smooth muscle cells | SYNTHASE | L-ARGININE | IN-VIVO | PERIPHERAL VASCULAR DISEASE | ISCHEMIA-REPERFUSION | HEMATOLOGY | EXPRESSION | Xanthine Dehydrogenase - metabolism | Hypoxia - drug therapy | Xanthine Dehydrogenase - antagonists & inhibitors | Male | Hypertension, Pulmonary - chemically induced | Hypoxia - metabolism | Sodium Nitrite - pharmacology | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Hypertension, Pulmonary - drug therapy | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - cytology | Disease Models, Animal | Myocytes, Smooth Muscle - enzymology | Mice, Inbred C57BL | Cells, Cultured | Administration, Inhalation | Rats | Hypertension, Pulmonary - metabolism | Monocrotaline - toxicity | Rats, Sprague-Dawley | Cell Division - drug effects | Mice, Knockout | Pulmonary Artery - cytology | Animals | Mice | Nitric Oxide - metabolism | Sodium Nitrite - pharmacokinetics | Chronic Disease | Cell proliferation | Control | Nitrites | Physiological aspects | Smooth muscle | Research | Pulmonary hypertension
Journal Article
Hypertension, ISSN 0194-911X, 05/2013, Volume 61, Issue 5, pp. 1091 - 1102
Journal Article
Circulation, ISSN 0009-7322, 06/2012, Volume 125, Issue 23, pp. 2922 - 2932
Background-Pulmonary hypertension (PH) is a multifactorial disease characterized by increased pulmonary vascular resistance and right ventricular failure;... 
eNOS | nitric oxide | xanthine oxidase endothelium | vasodilation | pulmonary hypertension | CARDIAC & CARDIOVASCULAR SYSTEMS | HYPOXIA | BLOOD-PRESSURE | REDUCTASE-ACTIVITY | THERAPY | ARTERIAL-HYPERTENSION | IN-VIVO | PERIPHERAL VASCULAR DISEASE | GENERATION | TISSUES | ISCHEMIA-REPERFUSION | HEMATOLOGY | Xanthine Dehydrogenase - metabolism | Antibiotics, Antineoplastic - toxicity | Nitrates - urine | Xanthine Dehydrogenase - antagonists & inhibitors | Nitrates - pharmacology | Male | Cyclic GMP - blood | Hypertension, Pulmonary - chemically induced | Hypertrophy, Right Ventricular - drug therapy | Hypoxia - metabolism | Pulmonary Circulation - physiology | Ventricular Pressure - physiology | Nitrites - blood | Hypoxia - prevention & control | Hypertension, Pulmonary - drug therapy | Nitric Oxide Synthase Type III - metabolism | Hypertrophy, Right Ventricular - metabolism | Bleomycin - toxicity | Disease Models, Animal | Nitrites - urine | Nitrates - blood | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Ventricular Pressure - drug effects | Hypertension, Pulmonary - metabolism | Nitric Oxide Synthase Type III - genetics | Nitrites - pharmacology | Mice, Knockout | Animals | Allopurinol - pharmacology | Mice | Pulmonary Circulation - drug effects | Animal Feed | Care and treatment | Nitric oxide | Development and progression | Research | Oxidoreductases | Xanthine | Health aspects | Pulmonary hypertension | endothelial nitric oxide synthase
Journal Article
The FEBS Journal, ISSN 1742-464X, 07/2008, Volume 275, Issue 13, pp. 3278 - 3289
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e37149
Journal Article
Journal Article